|
|
.
See Category: Neoplasms
See Header: Benign lipomatous neoplasm of other sites
ICD-10 (CM) Code and Descriptor
|
D17.79 |
Benign lipomatous neoplasm of other sites
|
D1779 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 22.44%
|
23.03%
|
17.49%
|
11.63%
|
7.93%
|
5.28%
|
3.54%
|
2.17%
|
1.65%
|
1.28%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D17.79*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J2704
|
INJ, PROPOFOL, 10 MG |
574
|
17,381
|
|
J3010
|
FENTANYL CITRATE INJECTION |
515
|
751
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
501
|
575
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
437
|
439
|
|
J2405
|
ONDANSETRON HCL INJECTION |
405
|
1,667
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
367
|
840
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
347
|
1,421
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
310
|
454
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
284
|
1,457
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
276
|
276
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
262
|
1,749
|
|
J7120
|
RINGERS LACTATE INFUSION |
236
|
287
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
190
|
564
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
171
|
15,594
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
155
|
155
|
|
J2001
|
LIDOCAINE INJECTION |
141
|
1,838
|
|
80048
|
METABOLIC PANEL TOTAL CA |
129
|
129
|
|
80053
|
COMPREHEN METABOLIC PANEL |
128
|
128
|
|
82565
|
ASSAY OF CREATININE |
126
|
126
|
|
82962
|
GLUCOSE BLOOD TEST |
118
|
144
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D17.79 related to the following DRG Codes:
606-607
|
